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Regulation of inositol transport by glucose and protein kinase C in
mesangial cells. Since inositol (Ins) depletion appears to be an important
mechanism of cell injury in diabetic glomerulopathy, we studied Ins
transport in cultured rat mesangial cells during hyperglycemia. High
glucose stimulated [3H]-Ins uptake by 50 to 90% within 24 hours in a
dose dependent manner. This effect was characterized by an increase in
the Vmax of a Natdependent Ins transporter (10.3 0.2 vs. 16.4 0.4
pmol/mg/min, P < 0.005). Since high glucose also induced activation of
protein kinase C (PKC) in permeabilized mesangial cells, we examined
the potential role of this enzyme in the stimulation of Ins transport by
glucose. Both PKC inhibition with H7 and staurosporine, and down
regulation of PKC by prolonged PMA (1.6 iLM) treatment inhibited the
stimulatory effect of glucose on Ins transport. In conclusion, high
glucose stimulates Na-dependent Ins transport in mesangial cells by a
mechanism mediated by PKC. This process may represent an important
adaptive response of mesangial cells to hyperglycemia.
The importance of myo-inositol (Ins) as a growth factor for
mammalian cells and of inositol lipids as critical mediators of
transmembrane signal transduction processes is now widely
recognized [1—3]. Ins deficiency can lead to alterations in cell
growth and abnormal phosphoinositide metabolism [1, 4, 5].
Intracellular Ins depletion has been observed in a variety of
tissues during diabetes mellitus and appears to be an important
factor in the pathogenesis of diabetic injury. Studies in strepto-
zotocin-induced diabetic rats have shown that the content of Ins
in sciatic nerve, autonomic superior cervical ganglion and renal
glomerulus is reduced as a result of hyperglycemia [6—9].
Moreover, pharmacologic dietary Ins supplementation admin-
istered to otherwise untreated streptozotocin-induced diabetic
rats has been shown to lead to restoration of both sciatic nerve
Ins content and pathologically slowed nerve conduction veloc-
ity to normal [10]. Emphasizing the importance of Ins depletion
in diabetes mellitus, several recent studies suggest that the
developmental abnormalities and birth defects observed in
offspring of diabetic mothers may be due to impairment of Ins
uptake by glucose resulting in Ins depletion in the conceptus
[11—13].
Inositol depletion due to inhibition of Ins uptake by high
concentrations of glucose has also been observed in cultured
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glomerular mesangial cells [41. Ins deficiency in mesangial cells
leads to abnormal phosphoinositide metabolism and cellular
dysfunction, which may underlie the abnormal glomerular
contractility and excessive mesangial matrix production ob-
served in early diabetic nephropathy [5, 14, 15]. A number of
recent studies have extensively characterized the competitive
inhibition of Ins uptake by glucose in a variety of cells [4,
16—231. Little is known, however, about the intracellular mech-
anisms that regulate Ins transport under physiologic and patho-
logic conditions and the adaptive and compensatory responses
that occur during Ins deficiency. In this study, we investigate
the effects of high concentrations of glucose on the activity of
the Ins transporter and the mechanisms that mediate these
effects. We report that in rat glomerular mesangial cells in
culture, hyperglycemia causes upregulation of Ins transport by
a mechanism involving glucose-induced activation of protein
kinase C.
Methods
Sprague-Dawley rats were obtained from the University of
Florida animal breeding facilities. Insulin-transferrin-selenium
(ITS), D-glucose, D-mannitol and D-myo-inositol were obtained
from Sigma Chemical (St. Louis, Missouri, USA). RPMI 1640
and minimum essential medium, fetal bovine serum, penicillin
and streptomycin were purchased from Fisher Scientific (Or-
lando, Florida, USA). [3H]-myo-inositol was purchased from
New England Nuclear (Boston, Massachusetts, USA). H7 was
obtained from Boehringer, staurosporine from Calbiochem and
phorbol myristate acetate (PMA) from Avanti Polar Lipids. The
peptide QKRPSQRSKYL (MBP4I4) was synthesized by the
Protein Chemistry Core Facility, Interdisciplinary Center for
Biotechnology Research, University of Florida, Gainesville,
Florida.
Preparation of mesangial cell cultures
All experiments were performed in cultured rat mesangial
cells between passages 2 and 12. Mesangial cells were har-
vested from male Sprague-Dawley rats weighing between 150 g
and 200 g following previously published techniques [24, 25].
Mesangial cell cultures were prepared after glomerular isolation
by mechanical sieving using standard aseptic techniques. The
isolated glomeruli were digested for 30 minutes with type IV
collagenase (750 U/mI) at 37°C and the glomerular "cores,"
which contain mostly mesangial and endothelial cells, were
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plated in tissue culture flasks and incubated at 37°C in a 5%
C02/95%air incubator. The culture medium consisted of RPMI
1640 containing 16% fetal bovine serum, 100 U/mi penicillin,
100 g/m1 streptomycin, S g/ml insulin, 5 g/ml transferrin and
5 nglml selenium. After three to four weeks, the mesangial cells
overgrow the other cells, become confluent and constitute more
than 90% of the cells in the culture. After two passages, no
endothelial or epithelial cells were seen and the cultures con-
sisted exclusively of mesangial cells. Mesangial cells were
identified using the following characteristics [24—26]: (1) spindle
or stellate shape under phase contrast microscopy; (2) presence
of microfilament bundles under transmission electron micros-
copy; (3) presence of immunofluorescence staining for anti-
smooth muscle specific myosin antibodies; (4) resistance to the
effects of the glomerular epithelial cytotoxin, aminonucleoside
of puromycin (100 g/ml); (5) absence of immunofluorescence
staining for anti-factor VIII antibodies which excludes the
presence of endothelial cells; and (6) contractile responses to
angiotensin II and norepinephrine.
Experimental conditions
In preparation for an experiment, mesangial cells were grown
to semiconfluence in 35 mm dishes for [3H]-Ins uptake, or in
96-well plates for protein kinase C determinations, and growth
was arrested by 72 to 96 hours of incubation in minimum
essential medium (MEM) containing 0.5% fetal bovine serum.
At the same time, insulin was withdrawn and myo-inositol was
adjusted to maintain a concentration of 30 M (total concentra-
tion taking into account myo-inositol present in serum) [27]. At
various times before experiments, mesangial cells matched for
cell line, number of passages and age were divided into two
groups: one control group was incubated in MEM as above with
5 mM glucose and one experimental group was incubated in the
same medium but with 30 m glucose (high glucose). The tissue
culture medium was replaced daily. In some experiments, a
second experimental group was used as control for osmolarity.
These cells were incubated in the above medium containing 5
m glucose and 25 m mannitol (high mannitol). The osmolar-
ities were 282 to 300 mOsm/kg H20 in the control, 300 to 320
mOsm/kg H20 in the high glucose and 300 to 316 mOsm!kg H20
in the high mannitol media. Cell viability, as assessed by
morphologic characteristics of the culture (absence of cell
detachment, vacuolization or abnormal granularity) and trypan
blue exclusion, was judged to be greater than 95% under all
conditions studied.
Determination of myo-inositol uptake
After predetermined periods of exposure to normal or high
glucose, mesangial cells were washed with HEPES-salt buffer
(HSB) (in mM: HEPES 20, NaCI 140, KCI 5, CaCl2 1, MgSO4
2.5, myo-inositol 0.05 and glucose 5, pH 7.40), incubated with 2
Ci/ml [3H1-Ins (10 to 20 Ci/mmol) at 37°C, and Ins uptake
measured at the times indicated. In agreement with what has
been previously described in the literature, Ins uptake was
found to be linear for over 30 to 60 minutes [4]. Ins uptake was
terminated by washing the cells with ice-cold PBS and adding
0.5 N NaOH. Aliquots were used for scintillation counting and
protein determination by the Lowry assay [281. Na-depen-
dent, specific Ins uptake was calculated as the difference
between uptake in HSB and uptake in Nat-free HSB containing
140 m choline Cl, and constituted 92 to 98% of total uptake.
For kinetic analysis of Ins uptake, Nat-dependent [3H]-Ins
uptake was measured in the presence of 0.2 to 96 M Ins, and
the Vmax and Km were determined by reciprocal (Lineweaver-
Burke) plots.
Measurement of protein kinase C activity
Protein kinase C activity was measured in permeabilized
mesangial cells using a modification of a previously described
assay based on the phosphorylation of a synthetic peptide
substrate corresponding to the phosphorylation site for protein
kinase C in myelin basic protein (QKRPSQRSKYL, MBP4.14)
[29, 301. Mesangial cells exposed to 5 or 30 m glucose for 24
or 48 hours were washed with HBS and incubated in 40 j.d of
permeabilization/kinase assay buffer for 15 minutes at 30°C.
This buffer contains NaC1 137 mM, KC1 5.4 m, Na phosphate
0.3 m, K phosphate 0.4 mM, glucose 1 mglml, HEPES 20 mM
(pH 7.2 at 30°), digitonin 50 tgIml, MgCI2 10 mrvi, 13-glycero-
phosphate 25 mM, [y-32P1 ATP 100 /.M (approx. 5000 cpm/
pmol), MBP414 100 M, EGTA 5 mM and CaCI2 2.5 m. After
15 minutes the reaction was terminated with 10 p1 of 25%
(wt/vol) trichloroacetic acid and 45 1.d of the acidified reaction
mixture were spotted on 2 x 2-cm phosphocellulose filter
squares (Whatman P-8 1). These were then washed batchwise in
three changes (500 ml each) of 75 m phosphoric acid and one
change of 75 m sodium phosphate (pH 7.5), and counted for
radioactivity. Results are expressed as fmol of MBP4.14 peptide
phosphorylated per mg protein per 15 minutes.
Protein kinase C inhibition, activation and depletion
For this group of experiments, mesangial cells were incu-
bated in 5 or 30 m glucose in the presence or absence of the
protein kinase C inhibitors H7 (10 /LM) or staurosporine (10 nM).
Direct PKC activation with low concentrations of PMA (10 nM)
and downregulation by prolonged (16 hr) incubation with 1.6
M PMA were also used to confirm the role of PKC in
mediating the observed changes in Ins transport.
Statistical analysis
Results are presented as mean standard error of the indicated
number of experiments performed in triplicate in four different cell
lines. Statistical analysis was performed using the Student's I-test
for paired and unpaired data, or analysis of variance (ANOVA)
and subsequent Scheffe's F-test (StatViewTM II, Abacus Con-
cepts, Inc. Berkeley, California, USA) as appropriate.
Results
Effects of glucose on myo-inositol uptake
To determine the effects of high glucose on Ins uptake,
mesangial cells were incubated under normal (5 mM) or high (30
mM) concentrations of glucose over periods of time ranging
from 1 hour to 10 days and Ins uptake was measured as
described above. Incubation in high glucose resulted in a
significant increase in the initial rate of Ins uptake which was
initially observed after four to six hours (12 to 19% increase)
and reached maximum within 24 to 48 hours (Fig. 1). This
maximum increase ranged in magnitude from 50 to 90%, was
sustained for as long as the high glucose conditions were
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Time, minutes
Fig. 1. Effect of high glucose on inositol uptake in mesangial cells.
Cells were exposed to control (A, 5 mM) or high glucose (E, 30 mM)
conditions for 48 hours and inositol uptake was measured between 0 to
15 minutes; P < 0.05 for 5 versus 30 mM glucose at each time point
between 3 and 15 minutes, N = 9.
maintained (experiments terminated at 10 days) and was depen-
dent on the concentration of glucose (Fig. 2). Incubation with
similar concentrations of mannitol (osmolarity control) did not
increase Ins uptake (Fig. 3). Thus, these results indicate that
incubation of mesangial cells in high concentrations of glucose
causes a concentration-dependent increase in the rate of Ins
uptake and that this effect is specific for glucose and not due to
changes in osmolarity.
To determine if the increase in Ins uptake induced by glucose
was due to an increase in specific Na-dependent transport or
due to an increase in nonspecific transport, Ins uptake was
measured under Nat-free conditions in cells exposed for 48
hours to normal or high glucose. Replacement of Na with
either choline or lithium resulted in an almost complete sup-
pression of Ins uptake in cells exposed to both normal or high
glucose conditions (Fig. 4). Thus, these results indicate that the
increase in Ins uptake induced by high glucose is due to an
increase in the activity of the specific Nat-dependent Ins
transporter and not due to nonspecific Ins transport.
To determine if the effects of high glucose on Ins uptake were
the result of increased number of transporter units or of higher
transporter affinity, Vmax and Km for Nat-dependent Ins trans-
port were determined using Lineweaver-Burke plots following
exposure to normal or high glucose. Incubation with high
glucose resulted in an increase in Vmax (10.3 0.2 vs. 16.4
0.4 pmol/mglmin, for 5 vs. 30 m glucose, respectively; P <
0.005) without change in Km (10.2 0.4 vs. 11.9 0.6 ,LLM, for
5 vs. 30 mi glucose, respectively; NS, N = 3). These results
suggest that high glucose enhances Ins transport by increasing
the number of Ins transporter units or through allosteric
changes in transporter velocity but not by changing the affinity
of the transporter.
To investigate if the induction of Ins transport by high
glucose required synthesis of Ins transporter protein and tran-






high glucose and coincubated with cycloheximide or actinomy-
cm D for 24 hours. Both cycloheximide and actinomycin D
prevented the increase in Ins transporter activity induced by
high glucose (Fig. 5). Thus, these results indicate that glucose
stimulation of Ins transport requires synthesis of new protein
and suggest an effect at the gene transcription level.
Role of protein kinase C in the up regulation of Ins transport
induced by glucose
We have previously demonstrated that elevated glucose
induces an increase in membrane-associated protein kinase C as
reflected by increased specific high affinity [3H1 phorbol 12,13-
dibutyrate ([3H] PDBu) binding in intact mesangial cells [511.
Since this technique measures the degree of protein kinase C
translocation from the cytosol to its site of activation in the
membrane and is considered to be a very precise index of
protein kinase C activation [31, 32], our previous results likely
reflect increased activation of the enzyme by glucose. This
prompted us to further investigate a potential role of protein
kinase C in the increase in Ins uptake induced by glucose. Since
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Fig. 2. Effects of increasing concentrations of glucose on inositol
uptake. Mesangial cells were incubated for 48 hours in medium con-
taining glucose in concentrations ranging from 5 to 30 m and inositol
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Fig. 3. Effect of mannitol on inositol uptake in mesangial cells. Cells
were incubated for 48 hours in medium containing 5 or 30 m glucose
(GL), or 30 mrs mannitol (Man). This was followed by determination of
inositol uptake over a 10 minute period. * P < 0.05, N = 6.
suggesting activation of the enzyme but does not measure
activity, we decided to measure protein kinase C activity
directly by phosphorylation of the highly specific synthetic
peptide substrate MBP414 as detailed above. As previously
described by other investigators [30], we found that phosphor-
ylation of MBP414 after PMA treatment was dependent on
peptide concentration and that it increased linearly with time.
Preliminary experiments showed that, in our system, maximal
phosphorylation occurred at a peptide concentration of 100 jM
and that a time course of 15 minutes was adequate for measure-
ment of protein kinase C activity (data not shown). Incubation
of mesangial cells in high glucose caused an increase in protein
kinase C activity as compared to controls (9.6 0.6 vs. 11.2
0.5 fmollmg at 24 hr, 7.9 0.4 vs. 11.8 0.6 fmol/mg at 48 hr;
5 vs. 30 m glucose, respectively; P < 0.05, N = 4; Fig, 6). This
effect was specific for glucose since mannitol at similar concen-
trations did not activate the enzyme (data not shown).
To investigate the potential role of protein kinase C in
mediating the effects of high glucose, Ins uptake was measured
after direct activation of this enzyme with low concentrations of
PMA (10 nM), and after inhibition with H7 or staurosporine in
Fig. 4. Inositol uptake in the presence (control) and absence of sodium
in mesangial cells exposed to 5 () or 30 ms's () glucose. Uptake was
measured over a 10 minute period. * P < 0.05 vs. glucose 5 mas in the
presence of sodium (control), N = 6.
normal or high glucose. PMA stimulated Ins uptake in a fashion
similar to high glucose, whereas H7 and staurosporine pre-
vented the increase in Ins uptake induced by high glucose (Fig.
7). In addition, both H7 and staurosporine decreased basal
levels of Ins uptake suggesting a role for protein kinase C in
maintaining basal rates of transporter activity (in pmollmg:
control 636.2 4.5; H7 356.9 29.9; staurosporine 540.6
16.2, P < 0.05 for either inhibitor versus control, N = 6).
Down regulation of protein kinase C was achieved by incu-
bation with high concentrations of PMA. Mesangial cells were
incubated with 1.6 M PMA for periods of time ranging from
five minutes to 16 hours and protein kinase C activity was
determined. After initial stimulation following short term expo-
sure to PMA, protein kinase C activity fell to basal levels within
two to four hours and tended to remain below these thereafter
(Fig. 8). These effects were similar in cells incubated in 5 or 30
m glucose, and are in agreement with what has been previ-
ously reported in the literature [33]. Down regulation of protein
kinase C with PMA resulted in a reduction in both basal and
glucose-stimulated Ins uptake (Fig. 9). Thus, the results of
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Fig. S. Effects of the protein synthesis inhibitor cycloheximide (CH, 20
pg/ml) and the mRJVA .svnthesis inhibitor actinomycin D (ACT, 5
p.g/ml) on the up regulation of inositol transport induced by high
glucose. Mesangial cells were incubated for 24 hours in medium contain
5 (control) or 30 msi (HG) glucose in the presence or absence of one of
the above inhibitors. Inositol uptake was then measured over a 10-
minute period as previously described. * p < 0.05, N = 6.
increase in protein kinase C activity and that the up regulation
of Ins transport by glucose requires activation of this enzyme.
Discussion
Ins deficiency has been proposed as one of the main patho-
genetic mechanisms leading to tissue injury in diabetes mellitus
[6—91. A number of studies have characterized the kinetics of
Ins transport in a variety of tissues and have investigated in
detail the competitive nature of the inhibition of Ins transport
by glucose [4, 16—23]. Little data is available, however, on the
adaptive responses that come into play when this competitive
interaction occurs. In these series of studies performed in rat
glomerular mesangial cells in culture, we demonstrate that
exposure to high extracellular concentrations of glucose results
in stimulation of Ins transport via activation of protein kinase C.
This effect is dose-dependent and specific for glucose, requires
synthesis of new protein and is the result of an increase in the
'Tmax of a specific Na-dependent Ins transporter. The stimu-
lation of Ins transport by glucose is mediated by protein kinase
Time, hours
Fig. 6. Protein kinase C activity measured as the rate of phosphoryla-
tion of MBP414 in digitonin-permeabilized mesangial cells. Cells were
incubated for 24 or 48 hours in medium containing 5 (D) or 30 mM ()
glucose and phosphorylation of MBP414 was then measured over a 15
minute period as described in the methods section. * P < 0.05, P <
0.005, N = 4.
C since the activity of this enzyme increases under high glucose
conditions and the effect of glucose on Ins transport can be
mimicked by treatment with PMA and inhibited by H7, stauro-
sporine or by down regulation of protein kinase C.
We have previously shown that high glucose causes desensi-
tization of receptor-mediated phosphoinositide hydrolysis in
mesangial cells and that this is probably due to negative
feedback by protein kinase C which becomes activated as a
result of enhanced de novo diacyiglycerol formation from
glucose [5]. This desensitization is completely prevented by Ins
supplementation which suggests that Ins may be playing a role
in modulating protein kinase C activity. In fact, early studies
have shown that supplemental Ins leads to increased shuttling
of diacylglycerol into membrane phosphatidylinositol resulting
in decreased intracellular levels of this lipid [34J. Furthermore,
recent studies have suggested the existence in plasma mem-
branes of a phosphatidylinositol synthetase which is responsi-
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Control HG HG + H7HG + ST PMA
Fig. 7. Effects of the protein kinase C inhibitors H7 (10 tM) and
staurosporine (ST, 10 nM) on glucose-induced stimulation of inositol
transport, and of PMA (10 nM) on basal inositol uptake. Inositol uptake
was measured over a 10-minute period following 48 hours of incubation
in medium containing 5 mat glucose (control), 30 m glucose (HG), 30
m glucose plus the respective inhibitors, or 5 m glucose plus PMA.
Both H7 and staurosporine prevented the increase in uptake observed
with high glucose, whereas PMA stimulated inositol uptake. * P < 0.05
vs. control, N = 6.
activation and has a Km for Ins in the low micromolar range,
similar to that of the transporter [35]. Conceivably, the Ins
transporter could be closely linked to this phosphatidylinositol
synthetase thus allowing Ins to rapidly shuttle diacylglycerol
into phosphatidylinositol to replenish membrane phosphoinosi-
tide pools, and at the same time constitute a protective cellular
mechanism by scavenging diacylglycerol and regulating the
degree of protein kinase C activation.
Under conditions of chronic hyperglycemia, intracellular
levels of Ins are reduced due to competitive inhibition of
transport by high concentrations of glucose, and protein kinase
C activity is increased as a result of de novo formation of
diacylglycerol from glucose [4, 5, 36]. In this situation, increas-
ing the rate of Ins uptake would tend to elevate intracellular Ins
levels as an appropriate compensatory response for replenish-
ing membrane phosphoinositide pools and scavenging diacyl-
glycerol to limit protein kinase C activity. However, the in-
crease in Ins transport may not be sufficient to overcome the
Time after PMA, hours
Fig. 8. Down regulation of protein kinase C activity after prolonged
treatment with PMA. Mesangial cells were treated with 1.6 iM PMA for
periods of time ranging from 5 minutes to 16 hours and protein kinase C
activity was measured as described. After transient initial stimulation,
protein kinase C activity fell and remained below basal levels. At 16
hours, the levels of protein kinase C activity in fmol/mg were: control
6.5 1.0 and PMA 2.8 1.3 (P < 0.05). Results shown are from cells
incubated in 5 mat glucose. Similar results were obtained in cells
incubated in 30 mat glucose. * P < 0.05 versus control. N = 4.
sustained competitive inhibition of Ins transport by high con-
centrations of glucose. Thus in diabetes mellitus, the marked
and sustained elevation in plasma glucose levels appears to
overwhelm this compensatory increase in Ins transport such
that total intracellular Ins remains depleted. Interestingly, al-
though a number of studies have shown that the intracellular
levels of Ins are depleted in diabetes mellitus and during in vitro
hyperglycemia, when the levels of membrane phosphoinosi-
tides have been studied these have usually been found to be
normal [5, 37]. It is therefore conceivable that, if as mentioned
above, plasma membrane phosphatidylinositol synthetase is
closely linked to the Ins transporter, the compensatory increase
in uptake could preferentially replete those Ins pools that are of
more critical importance in the moment to moment regulation of
receptor function without actually normalizing total intracellu-
lar Ins levels. It is also interesting, however, that some studies
have shown reversal of diabetic complications after dietary Ins
supplementation [10], suggesting that if the extracellular con-
centrations of this sugar are sufficiently elevated, the deleteri-
ous effects of high glucose may be prevented, perhaps by
mechanisms unrelated to the size of membrane phosphoinosit-
ide pools.
The fact that protein kinase C itself appears to regulate Ins
transport under both basal and high glucose conditions raises
the interesting possibility of this enzyme acting in a positive
feedback loop to increase intracellular Ins levels which in turn
would modulate enzyme activity. There is very little informa-
tion available regarding the physiologic regulation of Ins trans-
port in cells, and this study provides the first evidence that a
major intracellular signaling system is involved in the up
regulation of this transporter. It would be very interesting to
examine the effects of hormonal agents and growth factors that
act through the phosphoinositide cascade and protein kinase C
on the physiologic regulation of the Ins transporter.
The mechanisms by which protein kinase C up regulates Ins
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GL5 GL3O GL5 + PMAGL3O + PMA
Fig. 9. Effect of protein kinase C down regulation by prolonged
incubation (16 hr) with PMA on glucose-induced stimulation of inositol
transport. Cells were incubated in medium containing S (GLS) or 30
(GL3O) m glucose in the presence or absence of 1.6 jsM PMA and
inositol uptake was measured over a 10-minute period. Incubation with
PMA resulted in reduction in the basal levels of inositol uptake (GLS +
PMA vs. GL5, ** P < 0.05), and in marked blunting of glucose-induced
stimulation of inositol uptake. PMA, however, did not completely
abolish the effect of glucose (GL3O + PMA vs. GL5 + PMA, * P <
0,005 vs. GLS, P < 0.05). N = 9.
kinase C causes phosphorylation or stimulates the synthesis of
Na/Ins cotransporters, or that it phosphorylates or stimulates
synthesis of Na±/KFATPase thus providing more driving force
for NaJIns cotransport. The fact that the time course of
maximal effect is long (24 hr) and that it requires protein
synthesis makes it unlikely that a phosphorylation process is
exclusively responsible for the increase in Ins uptake. Con-
versely, these observations coupled with the finding of in-
creased Vm*x suggest that the effect of glucose is due to an
increase in the number of transporter molecules and not to
direct activation of the transporter by protein kinase C. Studies
are under way to elucidate the precise mechanisms responsible
for this effect.
In conclusion, exposure to high extracellular concentrations
of glucose results in stimulation of Ins transport in cultured rat
mesangial cells. This effect is specific for glucose and mediated
by protein kinase C which becomes activated as a result of
enhanced de novo diacyiglycerol formation from glucose. This
increase in Ins transport probably constitutes an adaptive
response by which cells try to compensate for intracellular Ins
depletion caused by glucose, and that may also serve as a
mechanism by which more intracellular Ins is made available
both to maintain membrane phosphoinositide pools, and to
scavenge diacylglycerol and limit protein kinase C activity.
Further studies should be conducted to better understand this
interaction and other aspects of the physiologic regulation of
Ins transport.
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